1. Siegel RL, Miller KD, Fuchs HE, Jemal A, "Cancer statistics, 2022," CA-A CANCER JOURNAL FOR CLINICIANS, vol. 72, no. 1, pp. 7–33, 2022.
2. Miller KD, Nogueira L, Devasia T, Mariotto AB, Yabroff KR, Jemal A, Kramer J, Siegel RL, "Cancer treatment and survivorship statistics, 2022," CA-A CANCER JOURNAL FOR CLINICIANS, vol. 72, no. 5, pp. 409–436, 2022.
3. "Anti-angiogenesis revisited: reshaping the treatment landscape of advanced non-small cell lung cancer";Choi SH;Arch Pharm Res,2022
4. Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target;Treps L;Pharmacol Ther,2021
5. Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies;Angara K;Histol Histopathol,2017